Safety
Sermorelin side effects: what the studies and programs report
Sermorelin side effects from the drug review, three small adult trials and program pages: flushing, injection-site pain, who should avoid it, and what is unknown.
By Julian Caraulani · Updated October 30, 2026
The most commonly reported sermorelin side effects are transient facial flushing and pain at the injection site (Prakash and Goa, PubMed 18031173). The adult trials were small and short, so rare and long-term effects are unknown. Sermorelin is compounded, not FDA-approved, and programs start at $94 a month; see every sermorelin price.
Below: what the published studies found, what four programs list, who is told to avoid it, how it differs from growth hormone, and what to ask your prescriber.
What the studies report
The reference drug review covered sermorelin as it was used when it was an approved product. It concluded that "intravenous single dose and repeated once daily subcutaneous doses of sermorelin are well tolerated", with flushing and injection-site pain the most common events (Prakash and Goa). That review was largely about children with growth hormone deficiency, so it is indirect evidence for adults buying a compounded product.
| Study | Who | Length | Adverse effects reported |
|---|---|---|---|
| Corpas 1992 | 10 healthy older men | 14 days, twice daily | Reported no effect on glucose, blood pressure or routine blood chemistry |
| Vittone 1997 | 11 healthy men aged 64 to 76 | 6 weeks | "No significant adverse effects were observed" |
| Khorram 1997 | 10 women and 9 men aged 55 to 71 | 16 weeks, a sermorelin analog | "The only adverse side-effect was transient hyperlipidemia, which resolved by the end of the study" |
The Corpas team wrote that treatment "did not affect fasting glucose, urinary C-peptide, blood pressure, or chemistry and hematology profiles" (Corpas 1992, PubMed 1379256). The largest adult trial had 19 people and the longest lasted 16 weeks, so none could detect uncommon problems. The Khorram trial also used a modified analog, not sermorelin itself.
What programs list
Programs describe side effects in their own words. These are provider statements, not trial results:
| Program | What it lists | Source |
|---|---|---|
| System Labs | "vivid dreams, mild redness at the injection site, occasional headache, or slight water retention in the hands and feet" | systemlabs.com |
| MadeMed | "temporary flushing or warmth and potential itching/redness at the injection site" | mademed.com |
| Hone Health | "Pain or redness at the injection site, Nausea, Headaches, Dizziness, Fatigue" | honehealth.com |
| Luvo Health | "pain, redness, or swelling at the injection site" as a more common effect needing a clinician's attention | luvohealth.com |
The lists overlap on injection-site reactions. Nausea, dizziness, fatigue and water retention appear on program pages but not in the small trials above, which shows how little controlled data sits behind these lists.
Who is told to avoid sermorelin
Hone Health states that "Men with a history or epilepsy, untreated hypothyroidism, or hyperglycemia should avoid sermorelin" and warns that "Sermorelin may worsen insulin resistance or contribute to fluid retention and joint pain" (Hone Health). The same page says men with a history of cancer, diabetes or untreated thyroid disorders should be aware of potential risks. Tell your prescriber about any of these before starting. Programs screen through a questionnaire and, at some, labs; the best programs page scores them partly on that oversight.
Sermorelin versus growth hormone side effects
Sermorelin prompts your own pituitary to release growth hormone, while injected growth hormone supplies it directly. The Khorram authors noted that studies of recombinant growth hormone in aging adults found "the adverse effects encountered limit its clinical utility", and proposed GHRH or its analogs as an alternative (Khorram 1997). That is a hypothesis from 1997, not a head-to-head result, and the Prakash review noted the recommended doses had not been directly compared with somatropin.
FDA status and product quality
Sermorelin is not FDA-approved today. The former brand, Geref, was withdrawn, and FDA found it was "not withdrawn from sale for reasons of safety or effectiveness" (Federal Register, March 4, 2013). It is not on FDA's category 2 list, and licensed pharmacies compound it on a prescription. Compounded drugs are not FDA-reviewed for safety or effectiveness, as Hone Health's page itself says. Our FDA status guide has the detail. Research-use-only products sold without a prescription are outside this site.
What to ask your prescriber
- Which labs they order before and during treatment, and whether they are included in the price.
- Whether your history (diabetes, thyroid, epilepsy, cancer) changes the advice.
- Which pharmacy compounds the product, and how to report a reaction.
- When to stop and call: swelling, spreading redness or severe pain at the site, or any allergic-type reaction.
Your prescriber sets the form and amount; we do not publish doses. Many programs bundle follow-up, so compare what the monthly price includes in our sermorelin cost guide and the sermorelin overview.
FAQ
What are the side effects of sermorelin?
The most commonly reported effects are transient facial flushing and pain or redness at the injection site. Programs also list headache, nausea, dizziness, fatigue, vivid dreams and mild water retention. In small adult trials, one reported no significant adverse effects and another reported only transient high blood lipids that resolved by the end of the study.
What are the sermorelin peptide side effects people should worry about?
Serious problems were not reported in the small trials, but those trials had 19 or fewer people and ran 16 weeks at most. That cannot rule out rare or long-term effects. Hone Health warns it may worsen insulin resistance or contribute to fluid retention and joint pain, so people with diabetes or thyroid conditions should raise them first.
Is sermorelin safe?
Safety evidence is limited. A drug review found single and repeated daily injections well tolerated, mostly in children with growth hormone deficiency. Adult trials were small and short. Sermorelin is compounded, so FDA has not reviewed the specific product for safety or effectiveness, and quality depends on the licensed pharmacy that prepares it.
Does sermorelin cause cancer?
We found no trial showing that sermorelin causes cancer, but none was designed or long enough to test it. Hone Health tells men with a history of cancer to be aware of potential risks. Anyone with a cancer history should ask an oncologist and the prescriber before starting.
Can sermorelin affect blood sugar?
Possibly. Hone Health says sermorelin "may worsen insulin resistance", and lists hyperglycemia as a reason to avoid it. In the Corpas and Vittone trials, glucose responses did not change, and Khorram found fasting glucose unaltered. Evidence is mixed and small, so people with diabetes should ask for monitoring.
Are there long-term side effects of sermorelin?
Unknown. The longest adult trial we found lasted 16 weeks, and it used an analog. No controlled study followed adults for years. If a program says long-term use is proven safe, ask for the study it relies on.
Compare prescription sermorelin programs on price, labs and oversight on our best peptide programs page, or see every plan on the price table.